Altered EphA5 mRNA expression in rat brain with a single methamphetamine treatment

Neuroscience Letters

Volumn 424, Issue 2, 2007, Pages 116-121

  Numachi, Yohtaro ^a   Yoshida, Sumiko ^b   Yamashita, Motoyasu ^c   Fujiyama, Ko ^c   Toda, Shigenobu ^d   Matsuoka, Hiroo ^c   Kajii, Yasushi ^e   Nishikawa, Toru ^e  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Associative learning; Dependence; Methamphetamine; Neuronal plasticity; Receptor tyrosine kinase; Synaptic connectivity

Indexed keywords

EPHRIN RECEPTOR A5; MESSENGER RNA; METHAMPHETAMINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DYSFUNCTION; CINGULATE GYRUS; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FRONTAL CORTEX; HABENULA; HIPPOCAMPUS; IN SITU HYBRIDIZATION; LIMBIC CORTEX; MALE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RAT; STATE DEPENDENT LEARNING;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; RATS; RATS, WISTAR; RECEPTOR, EPHA5; RNA, MESSENGER; TIME FACTORS;

EID: 34548019999     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.07.025     Document Type: Article

References (32)

1. Berke J.D., and Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25 (2000) 515-532
2. Brown A., Yates P.A., Burrola P., Ortuno D., Vaidya A., Jessell T.M., Pfaff S.L., O'Leary D.D., and Lemke G. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 102 (2000) 77-88
3. Caras I.W. A link between axon guidance and axon fasciculation suggested by studies of the tyrosine kinase receptor EphA5/REK7 and its ligand ephrin-A5/AL-1. Cell Tissue Res. 290 (1997) 261-264
4. Dufour A., Seibt J., Passante L., Depaepe V., Ciossek T., Frisen J., Kullander K., Flanagan J.G., Polleux F., and Vanderhaeghen P. Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. Neuron 39 (2003) 453-465
5. Ellsworth C.A., Lyckman A.W., Feldheim D.A., Flanagan J.G., and Sur M. Ephrin-A2 and -A5 influence patterning of normal and novel retinal projections to the thalamus: conserved mapping mechanisms in visual and auditory thalamic targets. J. Comp. Neurol. 488 (2005) 140-151
6. Feldheim D.A., Vanderhaeghen P., Hansen M.J., Frisen J., Lu Q., Barbacid M., and Flanagan J.G. Topographic guidance labels in a sensory projection to the forebrain. Neuron 21 (1998) 1303-1313
7. Gao P.P., Yue Y., Zhang J.H., Cerretti D.P., Levitt P., and Zhou R. Regulation of thalamic neurite outgrowth by the Eph ligand ephrin-A5: implications in the development of thalamocortical projections. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5329-5334
8. Gao W.Q., Shinsky N., Armanini M.P., Moran P., Zheng J.L., Mendoza-Ramirez J.L., Phillips H.S., Winslow J.W., and Caras I.W. Regulation of hippocampal synaptic plasticity by the tyrosine kinase receptor, REK7/EphA5, and its ligand, AL-1/Ephrin-A5. Mol. Cell Neurosci. 11 (1998) 247-259
9. Gerlai R., Shinsky N., Shih A., Williams P., Winer J., Armanini M., Cairns B., Winslow J., Gao W., and Phillips H.S. Regulation of learning by EphA receptors: a protein targeting study. J. Neurosci. 19 (1999) 9538-9549
10. Gerlai R. Eph receptors and neural plasticity. Nat. Rev. Neurosci. 2 (2001) 205-209
11. Halladay A.K., Tessarollo L., Zhou R., and Wagner G.C. Neurochemical and behavioral deficits consequent to expression of a dominant negative EphA5 receptor. Brain. Res. Mol. Brain Res. 123 (2004) 104-111
12. Hanson G.R., Ritter J.K., Schmidt C.J., and Gibb J.W. Response of mesolimbic substance P systems to methamphetamine treatment. Eur. J. Pharmacol. 128 (1986) 265-268
13. Ishikawa K., Nitta A., Mizoguchi H., Mohri A., Murai R., Miyamoto Y., Noda Y., Kitaichi K., Yamada K., and Nabeshima T. Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain. Int. J. Neuropsychopharmacol. 9 (2006) 407-415
14. Iwata S., Hewlett G.H., Ferrell S.T., Czernik A.J., Meiri K.F., and Gnegy M.E. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp Ther. 278 (1996) 1428-1434
15. Jassen A.K., Yang H., Miller G.M., Calder E., and Madras B.K. Receptor regulation of gene expression of axon guidance molecules: implications for adaptation. Mol. Pharmacol. 70 (2006) 71-77
16. Mackarehtschian K., Lau C.K., Caras I., and McConnell S.K. Regional differences in the developing cerebral cortex revealed by ephrin-A5 expression. Cereb. Cortex 9 (1999) 601-610
17. Maisonpierre P.C., Barrezueta N.X., and Yancopoulos G.D. Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression. Oncogene 8 (1993) 3277-3288
18. Martinez A., Otal R., Sieber B.A., Ibanez C., and Soriano E. Disruption of ephrin-A/EphA binding alters synaptogenesis and neural connectivity in the hippocampus. Neuroscience 135 (2005) 451-461
19. Mueller D., Chapman C.A., and Stewart J. Amphetamine induces dendritic growth in ventral tegmental area dopaminergic neurons in vivo via basic fibroblast growth factor. Neuroscience 137 (2006) 727-735
20. Robinson T.E., and Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11 (1999) 1598-1604
21. Robinson T.E., and Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 Suppl 1 (2004) 33-46
22. Sasaki K., Suda H., Watanabe H., and Yagi H. Involvement of the entopeduncular nucleus and the habenula in methamphetamine-induced inhibition of dopamine neurons in the substantia nigra of rats. Brain Res. Bull. 25 (1990) 121-127
23. Sato M., Numachi Y., and Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr. Bull. 18 (1992) 115-122
24. Shao H., Lou L., Pandey A., Verderame M.F., Siever D.A., and Dixit V.M. cDNA cloning and characterization of a Cek7 receptor protein-tyrosine kinase ligand that is identical to the ligand (ELF-1) for the Mek-4 and Sek receptor protein-tyrosine kinases. J. Biol. Chem. 270 (1995) 3467-3470
25. Sieber B.A., Kuzmin A., Canals J.M., Danielsson A., Paratcha G., Arenas E., Alberch J., Ogren S.O., and Ibanez C.F. Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Mol. Cell Neurosci. 26 (2004) 418-428
26. Takaki M., Ujike H., Kodama M., Takehisa Y., Yamamoto A., and Kuroda S. Increased expression of synaptophysin and stathmin mRNAs after methamphetamine administration in rat brain. Neuroreport 12 (2001) 1055-1060
27. Taylor V., Miescher G.C., Pfarr S., Honegger P., Breitschopf H., Lassmann H., and Steck A.J. Expression and developmental regulation of Ehk-1, a neuronal Elk-like receptor tyrosine kinase in brain. Neuroscience 63 (1994) 163-178
28. Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr. Psychiat. Rep. 4 (2002) 177-184
29. Umino A., Nishikawa T., and Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem. Int. 26 (1995) 85-90
30. Yue Y., Chen Z.Y., Gale N.W., Blair-Flynn J., Hu T.J., Yue X., Cooper M., Crockett D.P., Yancopoulos G.D., Tessarollo L., and Zhou R. Mistargeting hippocampal axons by expression of a truncated Eph receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10777-10782
31. Zhou R., Copeland T.D., Kromer L.F., and Schulz N.T. Isolation and characterization of Bsk, a growth factor receptor-like tyrosine kinase associated with the limbic system. J. Neurosci. Res. 37 (1994) 129-143
32. Zhou R. The Eph family receptors and ligands. Pharmacol. Ther. 77 (1998) 151-181